Mymetics Corp
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and nationa… Read more
Market Cap & Net Worth: Mymetics Corp (MYMX)
Mymetics Corp (PINK:MYMX) has a market capitalization of $45.56 ($45.56) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50616 globally and #15474 in its home market, demonstrating a -70.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mymetics Corp's stock price $0.00 by its total outstanding shares 151878 (151.88K).
Mymetics Corp Market Cap History: 2015 to 2025
Mymetics Corp's market capitalization history from 2015 to 2025. Data shows change from $2.73K to $45.56 (-31.97% CAGR).
Mymetics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mymetics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
81.00x
Mymetics Corp's market cap is 81.00 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.73K | $3.15 Million | -$3.01 Million | 0.00x | N/A |
| 2016 | $3.11K | $1.25 Million | -$5.96 Million | 0.00x | N/A |
| 2017 | $3.20K | $202.00K | -$4.11 Million | 0.02x | N/A |
| 2018 | $7.96K | $75.00K | -$4.17 Million | 0.11x | N/A |
| 2019 | $6.06K | $111.00K | -$4.19 Million | 0.05x | N/A |
| 2020 | $12.00K | $35.00K | -$4.16 Million | 0.34x | N/A |
| 2021 | $4.84K | $3.00K | -$4.73 Million | 1.61x | N/A |
| 2022 | $4.56K | $3.00K | -$4.80 Million | 1.52x | N/A |
| 2023 | $486.01K | $6.00K | -$11.57 Million | 81.00x | N/A |
Competitor Companies of MYMX by Market Capitalization
Companies near Mymetics Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Mymetics Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Mymetics Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Mymetics Corp's market cap moved from $2.73K to $ 45.56, with a yearly change of -31.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $45.56 | -70.00% |
| 2024 | $151.88 | -99.97% |
| 2023 | $486.01K | +10566.67% |
| 2022 | $4.56K | -5.96% |
| 2021 | $4.84K | -59.62% |
| 2020 | $12.00K | +97.99% |
| 2019 | $6.06K | -23.85% |
| 2018 | $7.96K | +148.34% |
| 2017 | $3.20K | +2.93% |
| 2016 | $3.11K | +13.89% |
| 2015 | $2.73K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Mymetics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.56 USD |
| MoneyControl | $45.56 USD |
| MarketWatch | $45.56 USD |
| marketcap.company | $45.56 USD |
| Reuters | $45.56 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.